Form D · Biotechnology

Pacific Diabetes Technologies, Inc.

Portland, OR · CIK 0001835476

Offering snapshot reported Nov 17, 2025 · SEC filing

Reported sold
$3.39M
Offering amount: $3.5M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 6, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.69M$3.39MOct 20, 2025: $2,920,000.00Oct 20, 2025Nov 17, 2025: $3,385,000.00Nov 17, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,920,000 → $3,385,000
  • Reported investors4 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 17, 2025Amendment$3,385,000$465,000vs Oct 20, 202515SEC filing
Oct 20, 2025Initial$2,920,000No comparison4SEC filing
Mar 14, 2025Initial$2,057,533No comparison5SEC filing
Sep 9, 2024Amendment$1,540,000$1,040,000vs Sep 13, 202317SEC filing
Sep 13, 2023Initial$500,000No comparison1SEC filing
Jun 2, 2021InitialYet to sellNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-561397

Source: Form D, filed Nov 17, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yobie Benjamin Director
Peter Eckenberg Director
Mark Huber Director
Ed La Cava Director
Edward La Cava Director
Christopher Marsh Director
Thomas Seidel Director, Executive
Thomas Seidl Director, Executive, Promoter
Kenneth Ward Director
Ken Ward Director
Hank Wuh Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
12172 Sw Garden Pl
Portland, OR, 97223